Category: Biotechnology
Global Biotechnology
-
Amino Acids
... CAGR of 6.0% over the analysis period 2024-2030. Glutamic Acid, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$13.6 Billion by the end of the analysis ... Read More
-
Small Molecule Kinase Inhibitors
... 2030, growing at a CAGR of 10.5% over the analysis period 2024-2030. The U.S. Market is Estimated at US$27.8 Billion While China is Forecast to Grow at 14.6% CAGR The Small Molecule Kinase Inhibitors market ... Read More
-
3D Cell Culture
... at a CAGR of 13.9% over the analysis period 2024-2030. Scaffold-based, one of the segments analyzed in the report, is expected to record a 14.0% CAGR and reach US$1.7 Billion by the end of the ... Read More
-
Agrigenomics
... 8.1% over the analysis period 2024-2030. Crops, one of the segments analyzed in the report, is expected to record a 8.6% CAGR and reach US$4.3 Billion by the end of the analysis period. Growth in ... Read More
-
Autoinjectors
... 15.9% over the analysis period 2024-2030. Disposable Autoinjectors, one of the segments analyzed in the report, is expected to record a 16.3% CAGR and reach US$101.1 Billion by the end of the analysis period. Growth ... Read More
-
Orthobiologics
... 4.2% over the analysis period 2024-2030. Viscosupplementation, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$4.1 Billion by the end of the analysis period. Growth in ... Read More
-
Protein Labeling
... CAGR of 6.0% over the analysis period 2024-2030. Kits, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$957.8 Million by the end of the analysis period. ... Read More
-
Q-TOF Mass Spectrometry
... at a CAGR of 7.8% over the analysis period 2024-2030. Biotechnology, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$593.6 Million by the end of the ... Read More
-
Rat Model
... CAGR of 7.1% over the analysis period 2024-2030. Inbred, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$901.6 Million by the end of the analysis period. ... Read More
-
Single-Cell Analysis
... CAGR of 18.6% over the analysis period 2024-2030. Cancer, one of the segments analyzed in the report, is expected to record a 20.5% CAGR and reach US$11.1 Billion by the end of the analysis period. ... Read More
-
Spine Biologics
... CAGR of 4.4% over the analysis period 2024-2030. Spinal Allografts, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$1.4 Billion by the end of the analysis ... Read More
-
Viral Inactivation
... CAGR of 11.6% over the analysis period 2024-2030. Kits & Reagents, one of the segments analyzed in the report, is expected to record a 11.5% CAGR and reach US$865.8 Million by the end of the ... Read More
-
Albumin
... 3.8% over the analysis period 2024-2030. Human Serum Albumin, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$902.4 Million by the end of the analysis period. ... Read More
-
Chromatography Accessories and Consumables
... 2030, growing at a CAGR of 14.2% over the analysis period 2024-2030. Solvents, Buffers & Adsorbents, one of the segments analyzed in the report, is expected to record a 16.0% CAGR and reach US$5.4 Billion ... Read More
-
Genomics and Proteomics Reagents, Research Kits and Analytical Instruments
... the year 2024, is expected to reach US$156.5 Billion by 2030, growing at a CAGR of 10.3% over the analysis period 2024-2030. Biochips & Microarrays, one of the segments analyzed in the report, is expected ... Read More
-
Microbiome Sequencing Services
... at a CAGR of 18.2% over the analysis period 2024-2030. Synthesis, one of the segments analyzed in the report, is expected to record a 16.8% CAGR and reach US$2.3 Billion by the end of the ... Read More
-
Polymerase Chain Reaction Consumables
... 2030, growing at a CAGR of 3.4% over the analysis period 2024-2030. PCR Tubes, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$250.5 Million by the ... Read More
-
Soft Tissue Allografts
... at a CAGR of 4.9% over the analysis period 2024-2030. Orthopedic, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$2.9 Billion by the end of the ... Read More
-
Hydrophobic Interaction Chromatography
... at a CAGR of 6.3% over the analysis period 2024-2030. Resins, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$263.1 Million by the end of the ... Read More
-
Laboratory Informatics
... CAGR of 8.4% over the analysis period 2024-2030. Life Science Companies, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$2.2 Billion by the end of the ... Read More
-
Microcarriers
... 8.3% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$2.5 Billion by the end of the analysis period. Growth in ... Read More
-
Lactase
... 5.3% over the analysis period 2024-2030. Yeast, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$235.9 Million by the end of the analysis period. Growth in ... Read More
-
Liquid Handling Systems
... at a CAGR of 4.6% over the analysis period 2024-2030. Automated, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$2.9 Billion by the end of the ... Read More
-
Medical Composites
... CAGR of 8.4% over the analysis period 2024-2030. Ceramic fiber composites, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$1.2 Billion by the end of the ... Read More
-
Protein Expression
... CAGR of 13.0% over the analysis period 2024-2030. Reagents, one of the segments analyzed in the report, is expected to record a 13.6% CAGR and reach US$4.6 Billion by the end of the analysis period. ... Read More
Research Assistance
